CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −324 | $49.97 | $16K | 51,748 |
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −369 | $51.48 | $19K | 51,379 |
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,564 | $52.32 | $134K | 48,815 |
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,638 | $53.38 | $141K | 46,177 |
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −123 | $53.87 | $7K | 46,054 |
| 2026-07-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −1,072 | 84,966 | ||
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +5,000 | $2.48 | $12K | 30,000 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −231 | $50.05 | $12K | 29,769 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −459 | $51.55 | $24K | 29,310 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,063 | $52.39 | $108K | 27,247 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,184 | $53.42 | $117K | 25,063 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −63 | $53.92 | $3K | 25,000 |
| 2026-07-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 116,268 | ||
| 2026-07-06 | Kunkel Lori Anne Director | Sale 10b5-1 | −4,111 | $49.98 | $205K | 47,773 |
| 2026-07-06 | Kunkel Lori Anne Director | Sale 10b5-1 | −5,889 | $50.84 | $299K | 41,884 |
| 2026-06-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −24,846 | $45.38 | $1.1M | 220,882 |
| 2026-06-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,477 | $45.00 | $66K | 219,405 |
| 2026-06-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −787,024 | $45.38 | $35.7M | 6,601,878 |
| 2026-06-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −46,776 | $45.00 | $2.1M | 6,555,102 |
| 2026-06-17 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +6,018 | $2.48 | $15K | 57,018 |
Page 3 of 37 · 724 trades